National Trends in the Utilization of Blood Transfusions in Total Hip and Knee Arthroplasty

Journal of Arthroplasty

Volumn 29, Issue 10, 2014, Pages 1932-1937

  Yoshihara, Hiroyuki ^a,b   Yoneoka, Daisuke ^c  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b Downstate Health Sciences University   (United States)

^c GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

Blood transfusion; Nationwide Inpatient Sample; Total hip arthroplasty; Total knee arthroplasty; Trend

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HOSPITAL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE HEMORRHAGE; PREDONATED AUTOLOGOUS BLOOD TRANSFUSION; SURGICAL PATIENT; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREND STUDY; UNITED STATES; CHILD; EPIDEMIOLOGY; FACTUAL DATABASE; HIP ARTHROPLASTY; INFANT; KNEE ARTHROPLASTY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRENDS; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84911004778     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2014.04.029     Document Type: Article

References (42)

1. Haien Z., Yong J., Baoan M., et al. Post-operative auto-transfusion in total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. PLoS One 2013, 8:e55073.
2. Feagan B.G., Wong C.J., Lau C.Y., et al. Transfusion practice in elective orthopaedic surgery. Transfus Med 2001, 11:87.
3. Cuenca J., García-Erce J.A., Martínez F., et al. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 2006, 46:1112.
4. So-Osman C., Nelissen R.G., Eikenboom H.C., et al. Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: a randomized pilot study. Transfus Med 2006, 16:321.
5. Strümper D., Weber E., Gielen W.S., et al. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion 2004, 44:1567.
6. Wells A.W., Mounter P.J., Chapman C.E., et al. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002, 325:803.
7. Morton J., Anastassopoulos K.P., Patel S.T., et al. Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 healthcare cost and utilization project nationwide inpatient sample database. Am J Med Qual 2010, 25:289.
8. Leahy M.F., Mukhtar S.A. From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice. Intern Med J 2012, 42:332.
9. Goldman M., Savard R., Long A., et al. Declining value of preoperative autologous donation. Transfusion 2002, 42:819.
10. Couvret C., Tricoche S., Baud A., et al. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates. Anesth Analg 2002, 94:815.
11. Wong C.J., Vandervoort M.K., Vandervoort S.L., et al. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 2007, 47:832.
12. Cuenca J., Garcia-Erce J.A., Martinez F., et al. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg 2007, 5:89.
13. Moonen A.F., Thomassen B.J., Knoors N.T., et al. Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial. J Bone Joint Surg (Br) 2008, 90:1079.
14. Keating E.M., Callaghan J.J., Ranawat A.S., et al. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strength. J Arthroplasty 2007, 22:325.
15. Weber E.W., Slappendel R., Hemon Y., et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: The European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005, 22:249.
16. Cip J., Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005, 45:1302.
17. Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anaesth Intensive Care 2003, 31:529.
18. Sukeik M., Alshryda S., Haddad F.S., et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg (Br) 2011, 93:39.
19. Healthcare Cost and Utilization Project (HCUP) Agency for Health-care Research and Quality Available at, [Last accessed Nov 1, 2013]. http://www.hcup-us.ahrq.gov/nisoverview.jsp.
20. Elixhauser A., Steiner C., Harris D.R., et al. Comorbidity measures for use with administrative data. Med Care 1998, 36(1):8.
21. Schmitges J., Sun M., Abdollah F., et al. Blood transfusions in radical prostatectomy: a contemporary population-based analysis. Urology 2012, 79:332.
22. Squires J.E. Risks of transfusion. South Med J 2011, 104:762.
23. Dodd R.Y. The risk of transfusion-transmitted infection. N Engl J Med 1992, 327(6):419.
24. Bihl F., Castelli D., Marincola F., et al. Transfusion-transmitted infections. J Transl Med 2007, 5:25.
25. Popovsky M.A., Whitaker B., Arnold N.L. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995, 35:734.
26. Goodnough L.T., Brecher M., Kanter M.H., et al. Transfusion medicine: second of two parts-blood conservation. N Engl J Med 1999, 340:525.
27. Rosencher N., Kerkkamp H.E., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43(4):459.
28. Faris P.M., Spence R.K., Larholt K.M., et al. The predictive power of baseline hemoglobin for transfusion risk in surgery patients. Orthopedics 1999, 22(1 Suppl.):s135.
29. Arora R.C., Legare J.F., Buth K.J., et al. Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective conservation strategies. Ann Thorac Surg 2004, 78:1547.
30. Litmathe J., Boeken U., Feindt P., et al. Predictors of homologous blood transfusion for patients undergoing open heart surgery. Thorac Cardiovasc Surg 2003, 51:17.
31. Magovern J.A., Sakert T., Benckart D.H., et al. A model for predicting transfusion after coronary artery bypass grafting. Ann Thorac Surg 1996, 61:27.
32. Moskowitz D.M., Klein J.J., Shander A., et al. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg 2004, 77:626.
33. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. Analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81:2.
34. Wallace E.L., Surgenor D.M., Hao H.S., et al. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993, 33:139.
35. Owens R.K., Crawford C.H., Djurasovic M., et al. Predictive factors for the use of autologous cell saver transfusion in lumbar spinal surgery. Spine 2013, 38:E217.
36. Carless P.A., Henry D.A., Moxey A.J., et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010, CD001888.
37. Gause P.R., Siska P.A., Westrick E.R., et al. Efficacy of intraoperative cell saver in decreasing postoperative blood transfusions in instrumented posterior lumbar fusion patients. Spine 2008, 33:571.
38. Warner D.O., Warner M.A., Schroeder D.R., et al. Changing transfusion practices in hip and knee arthroplasty. Transfusion 1998, 38:738.
39. Gombotz H., Rehak P.H., Shander A., et al. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007, 47(8):1468.
40. Lee G.C., Hawes T., Cushner F.D., et al. Current trends in blood conservation in total knee arthroplasty. Clin Orthop Relat Res 2005, 440:170.
41. Forgie M.A., Wells P.S., Laupacis A., et al. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: results of a meta-analysis. International Study of Perioperative Transfusion (ISPOT) Investigators. Arch Intern Med 1998, 158:610.
42. Spahn D.R., Moch H., Hofmann A., et al. Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 2008, 109:951.